Viewing Study NCT06697327


Ignite Creation Date: 2025-12-25 @ 5:10 AM
Ignite Modification Date: 2025-12-26 @ 4:15 AM
Study NCT ID: NCT06697327
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-05-14
First Post: 2024-11-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Daunorubicin + Cytarabine + Venetoclax in de Novo AML
Sponsor: Anhui Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module